Back to AMPE Stock Lookup

AMPE – Press Releases

Apr 10, 2014 08:00 AM Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs for Exclusive Rights to Zertane™ in Canada and Other Territories to Broaden its International Footprint
Apr 9, 2014 08:07 AM Results from the 20 weeks extension of the Ampion™ SPRING study to be presented at the Western Orthopedic Association Conference
Apr 2, 2014 08:00 AM Luoxis Obtains CE Marking for RedoxSYS™ Diagnostic System
Mar 11, 2014 08:00 AM Ampio Announces Investor call Thursday March 13, 4 PM EDT.
Mar 5, 2014 10:53 AM Ampio Pharmaceuticals, Inc. Closes Sale Of 9,775,000 Shares Of Common Stock
Feb 27, 2014 08:01 PM Ampio Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of 8,500,000 Shares Of Common Stock
Feb 24, 2014 07:00 AM Ampio Pharmaceuticals, Inc. Announces Public Offering of Common Stock
Feb 18, 2014 08:00 AM Ampio Completes Enrollment and Dosing in 2nd Pivotal Clinical Trial for Ampion™ (The STEP Study) for Its FDA Biological License Application (BLA)
Feb 13, 2014 06:00 AM Ampio Announces Positive Preliminary Biochemical Findings from the Synovial Fluid of the Knees Treated in the SPRING Study
Feb 4, 2014 08:00 AM Ampio Pharmaceuticals announces publication of findings for its lead product, Ampion™ in the journal PLOS ONE

Back to AMPE Stock Lookup